Antibodies neutralizing peginterferon alfa during retreatment of hepatitis C.
Annemiek A
AA
van der Eijk
Jan Maarten
JM
Vrolijk
Bart L
BL
Haagmans
D000328:Adult; D000906:Antibodies / Q000097:blood*; D000998:Antiviral Agents / Q000276:immunology* / Q000493:pharmacokinetics / Q000627:therapeutic use; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000276:immunology* / Q000493:pharmacokinetics / Q000627:therapeutic use; D008297:Male; D011092:Polyethylene Glycols / Q000493:pharmacokinetics / Q000627:therapeutic use; D011994:Recombinant Proteins
D000906:Antibodies; D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a